Felix Nunura¹*, Edwin Tulloch-Reid², Ahmed Soliman², Safiya Weekes³, Eldhose Basil³, Daina Baugh³ and Ernest Madu¹

¹Department of Cardiovascular Medicine, Heart Institute of the Caribbean, Kingston, Jamaica
²Department of Interventional Cardiology, Heart Institute of the Caribbean, Kingston, Jamaica
³Department of Medicine, Heart Institute of the Caribbean, Kingston, Jamaica

*Corresponding Author: Felix Nunura, Department of Cardiovascular Medicine, Heart Institute of the Caribbean, Kingston, Jamaica.

Received: May 31, 2021; Published: July 28, 2021

Citation: Felix Nunura., et al. “Syncope as a Long Term Effect of Coronavirus (“Long Covid”) in an Afro Caribbean Patient: A Case Report". Acta Scientific Medical Sciences 5.8 (2021): 161-164.

Abstract

While most persons with COVID-19 recover and return to normal health, some patients can have symptoms that can last for weeks or even months after recovery from acute illness. We describe an Afro Caribbean patient with symptoms of ‘long COVID’, and we posit that this condition may be related to a virus- or immune-mediated disruption of the autonomic nervous system resulting in a Vaso Vagal Syncope.

Keywords: COVID-19; SARS-CoV-2; Orthostatic Hypotension

Bibliography

1. Greenhalgh T., et al. “Management of post-acute Covid-19 in primary care”. BMJ 370 (2020): m3026.
2. Chan AT., et al. “The Coronavirus Pandemic Epidemiology (COPE) Consortium: A call to action”. Cancer Epidemiology, Biomarkers and Prevention 29 (2020): 1283-1289.
3. Khail Kanjwal., et al. “New-onset Postural Orthostatic Tachycardia Syndrome Following Coronavirus Disease 2019 Infection”. Innovations in Cardiac Rhythm Management 11 (2020): 4302-4304.
4. Goldstein DS. “The extended autonomic system, dyshomeostasis, and COVID-19”. Clinical Autonomic Research 30 (2020): 299-315.
5. Fudim M., et al. “Implications for neuromodulation therapy to control inflammation and related organ dysfunction in COVID-19”. Journal of Cardiovascular Translational Research 13 (2020): 894-899.
6. Konig MF., et al. “Preventing cytokine storm syndrome in COVID-19 using alfa-1 adrenergic receptor antagonists”. Journal of Clinical Investigation 137 (2020): 3345-3347.
7. Staedtke V., et al. “Disruption of a self-amplifying catecholamine loop reduced cytokine release syndrome”. Nature 564 (2018): 273-277.
8. Guilmot A., et al. “Immune-mediated neurological syndromes in SARS-CoV-2-infected patients”. Journal of Neurology (2020).
9. Ruzieh M., et al. “The role of autoantibodies in the syndromes of orthostatic intolerance: a systematic review”. Scandinavian Cardiovascular Journal 51 (2017): 243-247.
10. Li H., et al. “Agonistic autoantibodies as vasodilators in orthostatic hypotension: a new mechanism”. Hypertension 59 (2012): 402-408.
11. Fedorowski A., et al. “Antiadrenergic autoimmunity in postural tachycardia syndrome”. Europace 19 (2017): 1211-1219.
12. Li H., et al. “Autoimmune basis for postural tachycardia syndrome”. Journal of the American Heart Association 3 (2014): e000755.
13. Watari M., et al. “Autoimmune postural orthostatic tachycardia syndrome”. Annals of Clinical and Translational Neurology 5 (2018): 486-492.
14. Blitshteyn S., et al. “Autonomic dysfunction and HPV immunization: an overview”. Immunology Research 66 (2018): 744-754.
15. Gross A. “Fatigue plagues thousands suffering post-coronavirus symptoms”. Financial Times, 3 August (2020).
16. Freeman R., et al. “Orthostatic hypotension: JACC State-of-the-Art Review”. Journal of the American College of Cardiology 72 (2018): 1294-1309.
17. Jardine DL., et al. “The pathophysiology of the vasovagal response”. Heart Rhythm 15 (2018): 921-929.
18. Fenton AM., et al. “Vasovagal syncope”. Annals of Internal Medicine 133 (2000): 714-725.
19. Fedorowski A. “Postural orthostatic tachycardia syndrome: clinical presentation, aetiology and management”. Journal of Internal Medicine4 (2019): 352-366.
20. Vernino S and Stiles LE. "Autoimmunity in postural orthostatic tachycardia syndrome: current understanding". Autonomic Neuroscience 215 (2018): 78-82.
21. Johansson M., et al. “Long-haul post-COVID-19 symptoms presenting as a variant of postural orthostatic tachycardia syndrome: The Swedish experience". JACC Case Report 4 (2021): 573-580.
22. Wiersinga WJ., et al. “Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review". JAMA 324 (2020): 782-793.
23. Dani Melani., et al. “Autonomic Dysfunction in “long COVID”: rationale, physiology and management strategies”. Clinical Medicine1 (2020).

Copyright: © 2021 Felix Nunura., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.